Epidemiology of Hepatocellular Carcinoma in India – An Updated Review for 2024
-
Published:2024-11
Issue:6
Volume:14
Page:101447
-
ISSN:0973-6883
-
Container-title:Journal of Clinical and Experimental Hepatology
-
language:en
-
Short-container-title:Journal of Clinical and Experimental Hepatology
Author:
Giri SuprabhatORCID,
Singh AnkitaORCID
Reference51 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021
2. Report of National Cancer Registry Programme (ICMR-NCDIR), Bengaluru, India,2020
3. The Indian national association for study of the liver (INASL) consensus on prevention, diagnosis and management of hepatocellular carcinoma in India: the puri recommendations;Kumar;J Clin Exp Hepatol,2014
4. INASL task-force on hepatocellular carcinoma. 2019 update of Indian national association for study of the liver Consensus on prevention, diagnosis, and management of hepatocellular carcinoma in India: the puri II recommendations;Kumar;J Clin Exp Hepatol,2020
5. 2023 update of Indian national association for study of the liver consensus on management of intermediate and advanced hepatocellular carcinoma: the puri III recommendations;Kumar;J Clin Exp Hepatol,2024